Antifungal combination therapy: where we stand

Drug Resistance Updates

Volumn 1, Issue 2, 1998, Pages 89-92

  Sugar, Alan M ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002961839     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80022-8     Document Type: Article

References (26)

1. (Suppl). Stein D.K., and Sugar A.M. Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis 12 (1989) 221S-228S
2. Gallis H.A., Drew R.H., and Pickard W.W. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12 (1990) 308-329
3. Bennett J.E., Dismukes W.E., Duma R.J., et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 301 (1979) 126-131
4. Dismukes W.E., Cloud G., Gallis H.A., et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for 4 as compared with 6 weeks. N Engl J Med 317 (1987) 334-341
5. Zuger A., Louie E., Holzman R.S., Simberkoff M.S., and Rahal J.J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med 104 (1986) 234-240
6. Saag M.S., Powderly W.G., Cloud G.A., et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 326 (1992) 83-89
7. Van Der Horst C., Saag M., Cloud G., et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 337 (1997) 15-21
8. Jarvis W.R. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20 (1995) 1526-1530
9. Anaissie E., Gokaslan A., Hachem R., et al. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 15 5 (1992) 781-787
10. Dromer F., and Dupont B. The increasing problem of fungal infections in the immunocompromised host. J Mycologie Medicale 6 (1996) 1-6
11. Samonis G., and Bafaloukos D. Fungal infections in cancer patients: an escalating problem. In Vivo 6 2 (1992) 183-193
12. Sugar A.M. Use of amphotericin B with azole antifungal drugs: what are we doing?. Antimicrob Agents Chemother 39 (1995) 1907-1912
13. Schaffner A., and Frick P.G. The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. J Infect Dis 151 (1985) 902-910
14. Scheven M., Scheven C., Hahn K., and Senf A. Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: Dependency on lipophilia. Mycoses 38 (1995) 14-21
15. Scheven M., and Schwegler F. Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro. Antimicrob Agents Chemother 39 (1995) 1779-1783
16. Ryley J. Screening and evaluation in vivo. In: Ryley J. (Ed). Chemotherapy of Fungal Diseases Handbook of Experimental Pharmacology vol 96 (1990), Springer-Verlag, Berlin 129-147
17. Sugar A.M., Hitchcock C.A., Troke P.F., and Picard M. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Antimicrob Agents Chemother 39 (1995) 598-601
18. Sanati H., Ramos C., Bayer A., and Ghannoum M. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Antimicrob Agents Chemother 41 (1997) 1345-1348
19. George D., Kordick D., Miniter P., Patterson T.F., and Andriole V.T. Combination therapy in experimental invasive aspergillosis. J Infect Dis 168 (1993) 692-698
20. Anaissie E.J., Hachem R., Karyotakis N.C., et al. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother 38 (1994) 2541-2544
21. Polak A. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis, and wangiellosis in mice. Chemotherapy 33 (1987) 381-395
22. Schaffner A., and Bohler A. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism. Mycoses 36 11-12 (1993) 421-424
23. Nucci M., Pulcheri W., Bacha P.C., et al. Amphotericin B followed by itraconazole in the treatment of disseminated fungal infections in neutropenic patients. Mycoses 37 11-12 (1994) 433-437
24. Denning D.W., Lee J.Y., Hostetler J.S., et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97 (1994) 135-144
25. Albert M.M., Graybill J.R., and Rinaldi M.G. Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination. Antimicrob Agents Chemother 35 (1991) 1721-1725
26. Sugar A.M. Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination. Antimicrob Agents Chemother 35 (1991) 1669-1671